Quantcast

Latest thyroid cancer Stories

2014-04-23 20:23:23

WHIPPANY, N.J. and THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., April 23, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that The Lancet published online results from the Phase 3 DECISION trial which demonstrated that NEXAVAR(®) (sorafenib) tablets significantly extended the time patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma that is...

2014-04-17 23:01:33

The Firm is actively evaluating Byetta lawsuit claims on behalf of diabetics who allegedly developed pancreatitis, pancreatic cancer or thyroid cancer after taking the incretin mimetic. New York, NY (PRWEB) April 17, 2014 More than 30 federal cases have joined a federal diabetes drug litigation that includes an increasing number of Byetta lawsuit (http://www.byettalawsuit.com/) filings, as well as claims over similarly-designed medications, Bernstein Liebhard LLP reports. Court documents...

2014-04-09 16:23:19

LONDON, April 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Thyroid Cancer Global Clinical Trials Review, H2, 2013Thyroid Cancer Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Thyroid Cancer Global Clinical Trials Review, H2, 2013" provides data on the Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thyroid Cancer. It includes an overview...

2014-03-29 23:01:26

The Firm is investigating Byetta lawsuits on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer due to their use of Byetta. New York, New York (PRWEB) March 29, 2014 As Byetta lawsuits (http://www.byettalawsuit.com) continue to move forward in federal court, Bernstein Liebhard LLP notes that a newly published study is raising questions about the costs and benefits associated with newer medications used in the treatment of Type 2 diabetes....

2014-03-01 23:01:16

The Firm is actively investigating Byetta lawsuit claims on behalf of diabetics who may have been diagnosed with pancreatitis, pancreatic cancer or thyroid cancer after taking the medication. New York, New York (PRWEB) March 01, 2014 The federal litigation of Byetta lawsuits (http://www.byettalawsuit.com/) and other claims involving similar Type 2 diabetes drugs has grown to include more than 300 cases, Bernstein Liebhard LLP reports. According to a Case List updated February 19th by the...

2014-02-25 13:41:11

A new analysis has found that adolescents and young adults who develop thyroid cancer as a secondary cancer have a significantly greater risk of dying than those with primary thyroid cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the findings stress the importance of screening young cancer survivors to detect early signs of a potentially life-threatening thyroid malignancy. Thyroid cancer is one of the five most common malignancies in...

2014-02-22 23:01:04

The Firm is evaluating Byetta lawsuits on behalf of patients who allegedly developed pancreatic cancer, pancreatitis, or thyroid cancer due to their use of the Type 2 diabetes medication. New York, New York (PRWEB) February 22, 2014 A Byetta lawsuit (http://www.byettalawsuit.com) Plaintiff has withdrawn her motion seeking the consolidation of all federal claims involving allegations that the Type 2 diabetes drug caused patients to develop thyroid cancer, Bernstein Liebhard LLP reports....

2014-02-17 23:03:29

The Firm is investigating Byetta lawsuits on behalf of individuals who developed pancreatic cancer, thyroid cancer or pancreatitis, allegedly due to their use of the Type 2 diabetes medication. New York, New York (PRWEB) February 17, 2014 The federal court overseeing dozens of Byetta lawsuits (http://www.byettalawsuit.com) and other product liability claims involving Type 2 diabetes drugs known as incretin mimetics is now considering proposals for the case management of the...

2014-02-14 23:23:27

Molecular diagnostic testing, which analyzes thyroid nodule FNA biopsy specimens, is rapidly emerging as a useful tool for evaluation of cytologically indeterminate thyroid nodules that otherwise would require diagnostic surgery. Portland, OR (PRWEB) February 14, 2014 Molecular diagnostic testing, which analyzes thyroid nodule FNA biopsy specimens, is rapidly emerging as a useful tool for evaluation of cytologically indeterminate thyroid nodules that otherwise would require diagnostic...

2014-02-13 23:01:43

The Firm is evaluating Byetta lawsuits and other legal claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis, and thyroid cancer due their use of incretin mimetic medications used to treat Type 2 diabetes. New York, New York (PRWEB) February 13, 2014 As Byetta lawsuits (http://www.byettalawsuit.com) and other legal claims involving incretin mimetic drugs continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that U.S. health regulators...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related